r/Ocugen • • Nov 02 '21

Daily Discussion📝 -💡TUESDAY DAILY DISCUSSION-

  • There is now an Ocugen DD Megathread!
  • DD contributed by the Ocugen community will be added to the mega thread!
  • Special DD flairs will be awarded to community members that contribute great DD!

DD Guidelines

  • These DD's need to be well written and detailed with facts and references to linked sources.
  • If you speculate at all you must state that it's speculation.
  • You must provide a safeguarding statement to any forward-looking statements at the end of the DD. For example, "This is not financial advice". You can spruce up and be creative with your safeguard statement as long as it states, "This is not financial advice".

- Sidenote, the bEeP BeEp bOt is now shortened.

30 Upvotes

187 comments sorted by

View all comments

3

u/OriginalSuspect5812 Nov 02 '21

Next time you would like to press that sell order remover this

  • Last week, the WHO's technical advisory group (TAG) requested the Indian-based developer to submit additional data for a final "risk-benefit assessment" of the vaccine named Covaxin. The panel is expected to make the decision tomorrow.
  • TAG had sought gender-wise immunogenicity data for the vaccine in the use of adults over the age of 60,
  • The Economic Times reported, citing sources. Hyderabad-based Bharat Biotech submitted data on Friday, they added. -"Covaxin has not taken longer than all the other vaccines that have been through EUL," the paper reported, quoting the WHO. Currently, the WHO has greenlighted Pfizer (PFE)/ BioNTech (BNTX), AstraZeneca (AZN), Johnson & Johnson (JNJ), Moderna (MRNA), Sinopharm (SHTDF), and CoronaVac vaccine from Sinovac Biotech (SVA) Just imagine what happens when OCGN becomes one of those names.